Precipio, Inc.

PRPO Healthcare Diagnostics & Research

Precipio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $24.0 million, up 29.8% from fiscal 2024. In the quarter to June 2026, revenue grew 24.2%, EPS fell 340.0%, free cash flow grew 79.6% and total debt rose 47.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

21.38 1.16 −5.15%
Market cap
$40.4M
P/E
0.0×
Fwd P/E
15.4×
Dividend yield
—
F-score
6/9
Altman Z
−2.40
Beneish M
−1.62
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
1.63 1.73 1.53 1.28
P/FCF ratio
56.09 80.32 102.74 49.46
P/Operating CF
67.05 696.52 100.78 2,913.11
P/B ratio
3.00 3.15 2.53 2.12
EV/Sales
1.55 1.65 1.46 1.22
EV/EBITDA
142.41 1,709.78 63.40 0.00
EV/FCF
53.43 77.02 97.67 47.05
Current Ratio
1.77 1.56 1.61 1.27
Net Debt/EBITDA
16.15 1.89 (1.79) (3.77)
Debt/Equity
0.07 0.05 0.06 0.06
Earnings Yield
(2.58%) (1.88%) (1.09%) (4.61%)
Free Cash Flow Yield
1.78% 1.25% 0.97% 2.02%
Free Cash Flow per Share
0.30 0.01 0.18 (0.03)
Book value per Share
8.26 7.95 9.07 8.40
Free Cash Flow
0.53 0.01 0.29 (0.04)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates